Coagulation Diagnostic Testing Markets

1
Coagulation Diagnostic Testing Markets 
 

• Bharat Book Bureau

2
Summary

• Coagulation testing, which encompasses both
  laboratory and point of care (POC) testing, will
  continue to be one of the most important segments
  of the in vitro diagnostics market for the
  foreseeable future. Many of the new models of
  laboratory coagulation testing devices and
  reagents, which are dominated by prothrombin time
  (PT) and activated partial thromboplastin time
  (aPTT), will include upgrades such as greater
  automation and the integration of more esoteric
  coagulation tests such as D-dimer and
  antiphospholipid assays. This TriMark
  Publications report provides a comprehensive
  examination of the coagulation and antiplatelet
  testing market. It examines the available and
  emerging technologies being utilized by the
  coagulation and antiplatelet testing field and
  describes the current product lines of almost all
  of the companies known to be marketing,
  manufacturing or developing instruments and
  reagents for coagulation and antiplatelet
  testing. 

3
Continue

• Moreover, the study defines the dollar
  volume of sales, both in the U.S. and worldwide,
  and analyzes the factors that influence the size
  and growth of the market. Each company is
  discussed in extensive depth with a section on
  its history, product line, business and marketing
  analysis, and a subjective commentary of the
  company's market position. Detailed tables and
  charts with sales forecasts and market data are
  also included.  

4
Table Of Contents

• 1. Overview 101.1 Statement of Report
  101.2 About this Report 111.3 Scope of the
  Report 111.4 Objectives 121.5 Methodology
  121.6 Executive Summary 132. Introduction to
  Hemostasis and Blood Coagulation 152.1 Vascular
  Constriction 152.2 Platelet Activation and
  Platelet Plug Formation 152.3 Blood Coagulation
  162.3.1 Coagulation Cascade 162.3.2 Current
  Cell-Based Model for Blood Coagulation 172.3.2.1
  Initiation of Blood Coagulation 172.3.2.2
  Amplification of Blood Coagulation 18

5
Continue

• 2.3.2.3 Propagation of Blood Coagulation
  192.4 Fibrinolysis 192.5 Regulation of
  Coagulation 202.5.1 Tissue Factor Pathway
  Inhibitor 202.5.2 Antithrombin 212.5.3
  Thrombomodulin and Protein C 222.5.4 Protein Z
  and Protein Z-dependent Protease Inhibitor
  222.5.5 Prostacyclin 222.6 Clinical
  Significance of Blood Coagulation and
  Anticoagulants 222.6.1 Overview of Bleeding
  Disorders 232.6.2 Overview of Hypercoagulable
  Disorders 242.6.3 Anticoagulation Therapy in
  Cardiovascular Disease 252.7 Overview of
  Commonly Used Drugs to Regulate Coagulation
  272.7.1 Heparin (Unfractionated) 282.7.2 Low
  Molecular-Weight Heparin (LMWH) 282.7.3
  Fondaparinux 29

6
For More Information You Can Visit-

• http//www.bharatbook.com/healthcare-market-r
  esearch-reports/coagulation-diagnostic-testing-mar
  kets.html
• Or visit us at
• Bharat
  Book Bureau
  Phone [phone]
  Fax [phone]
  Toll Free No for
  USA/Canada 1-866-279-8368
  E-mail info_at_bharatbook.com
  Website
  www.bharatbook.com
  Twitter https//twitter.com/BharatBook
  Blog
  http//blog.bharatbook.com/